Prolonged fibrinolysis time is a risk factor for mortality in patients with chronic kidney disease - a propensity score matched analysis
Event: ESC Congress 2023
Topic: Renal Failure and Cardiovascular Disease
Session: Renal failure and clinical outcomes
Clinical implications and risk factors for QRS width progression in heart failure patients
Event: ESC Congress 2022
Topic: Cardiac Resynchronisation Therapy (CRT)
Session: Chronic heart failure - ICD, device and cardiac resynchronisation therapy
Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study
Event: ESC Congress 2020
Topic: Biomarkers
Session: Atrial Fibrillation, Platelet Aggregation and Outcomes
Platelet complement C3 deposition predicts platelet hyperactivity in patients with type II diabetes
Event: ESC Congress 2019
Topic: Platelets, Haemostasis, Coagulation
Session: The vascular inflammation coagulation interface
Dyslipidemia associated oxidised ldl induces platelet hyperactivity through a cd36-dependent activation of pde3a
Event: ESC Congress 2018
Topic: Platelets, Haemostasis, Coagulation
Session: Platelets, haemostasis and coagulation
Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by CD36 and PLC gamma 2 dependent ROS production
Event: ESC Congress 2017
Topic: Platelets
Session: State of the art in platelet biology
ESC 365 is supported by
